DL-AP5 sodium salt, NMDA glutamate site antagonist
DL-AP5 sodium salt, NMDA glutamate site antagonist
Be the first to review this product! Submit a review
|
(35 Publications)
DL-AP5 sodium salt (ab120271) is a NMDA receptor glutamate site antagonist. MW 219.11, Purity >99%.
- Cited in over 25 publications
- Available in different sizes to fit your experimental needs
查看别名
AMPA 1, AMPA-selective glutamate receptor 1, GLUH1, GRIA1_HUMAN, GluA1, GluR-1, GluR-A, GluR-K1, Glutamate receptor 1, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, HBGR1, MGC133252, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243
- Chemical Structure
Lab
Chemical Structure - DL-AP5 sodium salt, NMDA glutamate site antagonist (AB120271)
2D chemical structure image of ab120271, DL-AP5 sodium salt, NMDA glutamate site antagonist
产品详情
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Pathways
The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.
Biological function summary
The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.
文献 (35)
Recent publications for all applications. Explore the full list and refine your search
Molecular autism 16:26 PubMed40241211
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:8841 PubMed39396999
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed38470230
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:351-377 PubMed38177913
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:5285 PubMed37648685
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112699 PubMed37368752
2023
Applications
Unspecified application
Species
Unspecified reactive species
Current protocols 3:e786 PubMed37272700
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 166:248-264 PubMed37243578
2023
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:267 PubMed36918719
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 43:2002-2020 PubMed36759195
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com